Učitavanje...

Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Med Case Rep
Glavni autori: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://ncbi.nlm.nih.gov/pubmed/25488584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!